You are here

  • Home
  • Archive
  • Volume 4, Issue 1
  • Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial

Article info

Article menu

This article has a correction. Please see:

XML
Cardiovascular and metabolic risk
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial

Authors

  • Kohjiro Ueki Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Molecular Sciences on Diabetes, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan Translational Systems Biology and Medicine Initiative (TSBMI), The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Takayoshi Sasako Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Department of Molecular Diabetic Medicine, Diabetes Research Center, National Center for Global Health and Medicine, Tokyo, Japan Translational Systems Biology and Medicine Initiative (TSBMI), The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Masayuki Kato Fiore Kenshin Clinic, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Yukiko Okazaki Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Sumie Okahata Division of Diabetes and Metabolism, Toho University Ohashi Medical Center, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Hisayuki Katsuyama Department of Internal Medicine, National Center for Global Health and Medicine, Kohnodai Hospital, Chiba, Japan PubMed articlesGoogle scholar articles
  • Mikiko Haraguchi Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Ai Morita Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Ken Ohashi Department of General Internal Medicine, National Cancer Center Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kazuo Hara Department of Diabetes, Endocrinology and Metabolism, Tokyo Medical University, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Atsushi Morise Department of Endocrinology and Metabolism, Toranomon Hospital, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Kazuo Izumi Division of Rare/Intractable Disease Research, Department of Research Promotion, Japan Agency for Medical Research and Development, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Yasuo Ohashi Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Mitsuhiko Noda Department of Diabetes Research, National Center for Global Health and Medicine, Tokyo, Japan PubMed articlesGoogle scholar articles
  • Takashi Kadowaki Department of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan Translational Systems Biology and Medicine Initiative (TSBMI), The University of Tokyo, Tokyo, Japan PubMed articlesGoogle scholar articles
  • the J-DOIT3 Study Group
    Google scholar articles
  1. Correspondence to Dr Takashi Kadowaki; kadowaki-3im{at}h.u-tokyo.ac.jp
View Full Text

Citation

Ueki K, Sasako T, Kato M, et al
Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial
BMJ Open Diabetes Research and Care 2016;4:e000123. doi: 10.1136/bmjdrc-2015-000123

Publication history

  • Received June 10, 2015
  • Revised October 22, 2015
  • Accepted October 26, 2015
  • First published January 25, 2016.
Online issue publication 
January 03, 2017

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/